This announcement is a separate document:
国邦医药:国邦医药2022年半年度报告
Guobang Pharmaceutical: Guobang Pharmaceutical's 2022 Semi-Annual Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
04:27
The head of Blackstone's North American private equity stated: We are confident in the USA economy.
BX+2.51%
04:24
The USA Bureau of Labor Statistics has repeatedly made errors in its data release, leading to the withdrawal of key outsourced positions.
04:21
The USA Treasury announced a loan of 20 billion USD to Ukraine.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.